Deals this week: Synthetic Biologics, Bayer, HitGen

Synthetic Biologics has raised $12m through the private placement of 120,000 series A preferred shares priced at $100 a share.

Source: Drug Development Technology - September 14, 2017 Category: Pharmaceuticals Source Type: news